# A. Murray Brunt

Source: https://onco.cc/people/murray-brunt/  
OnCo record `murray-brunt` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led FAST-Forward, which cut breast radiotherapy from three weeks to one with no loss of effectiveness.

## Summary

Murray Brunt (Keele University) was chief investigator of FAST-Forward, the UK trial of 4,000 women showing that 26 Gy in five fractions over one week is non-inferior to 40 Gy in 15 fractions for local recurrence and normal tissue effects after breast conservation, a result adopted rapidly during the COVID-19 pandemic and now standard in many countries. He also led the FAST trial of five-fraction schedules over five weeks.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: radiotherapy; breast; hypofractionation
- Role: Professor of Clinical Oncology, Keele University; Consultant, University Hospitals of North Midlands
- Specialisms: Breast radiotherapy; Hypofractionation; Radiotherapy trials

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Brunt%20AM%5BAuthor%5D%20FAST-Forward

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)

---
JSON: https://onco.cc/api/v1/entities/murray-brunt.json